Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: A double-blind, randomized, placebo-controlled phase III trial

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1182-1190

  Binder, G ^a   Weber, S ^a   Ehrismann, M ^a   Zaiser, N ^b   Meisner, C ^b   Ranke, M B ^a   Maier, L ^c   Wudy, S A ^d   Hartmann, M F ^d   Heinrich, U ^e   Bettendorf, M ^e   Doerr, H G ^f   Pfaeffle, R W ^g   Keller, E ^g  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIONE; HYDROCORTISONE; MANNITOL; PLACEBO; PRASTERONE; PRASTERONE SULFATE; RECOMBINANT GROWTH HORMONE;

ACNE; ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ANKLE JOINT PAIN; ANKLE SPRAIN; ANXIETY; ARTHRALGIA; ARTICLE; ATRICHIA PUBIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; CROSSOVER PROCEDURE; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FINGER FRACTURE; HAIR DISEASE; HAIR GROWTH; HEADACHE; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; HUMAN RELATION; HYPOPITUITARISM; MOOD CHANGE; MOUSTACHE; MULTICENTER STUDY; NONORGANIC ACRAL PARESTHESIA; PARESTHESIA; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PRASTERONE DEFICIENCY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RHINITIS; SIDE EFFECT; SYMPTOM CHECKLIST 90; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINARY EXCRETION;

EID: 65249120344     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1982     Document Type: Article

References (29)

1. Achermann JC, SivermanBL 2001 Dehydroepiandrosterone replacement for patients with adrenal insufficiency. Lancet 357:1381-1382
2. Løvås K, Loge JH, Husebye ES 2002 Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56:581-588
3. Abraham GE 1994 Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 39:340-346
4. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P 2000 Premature adren- arche-normal variant or forerunner of adult disease? Endocr Rev 21:671-696
5. Sulcova J, Hill M, Hampl R, Starka L 1997 Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 154:57-62
6. Labrie F, Luu-TheV, Belanger A, LinS-X,Simard J, Pelletier G, Labrie C 2005 Is dehydroepiandrosterone a hormone? J Endocrinol 187:169-196
7. Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G 1997 Panhypopituitarism as a model to study the metabolism of dehydro- epiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 82:2578-2585
8. Wit JM, Langenhorst VJ, Jansen M, Oostdijk W, Van Doorn J 2001 Dehy droepiandrosterone-sulfate (DHEAS) treatment for atrichia pubis. Horm Res 56:134-139
9. Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B 1998 Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83:1928-1934
10. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepi and roster one replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
11. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK 2000 Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650-4656
12. Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA 2002 Low dose dehydroepiandroster one affects behavior in hypopituitary and rogen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87:2046-2052
13. van Thiel SW, RomijnJA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B, Smit JW 2005 Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: arandomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90:3295-3303
14. Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK 2008 Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 93:400-409
15. Løvås K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebø BG, Myking OL, Kampe O, Husebye ES 2003 Replacement of dehydroepiandro- sterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88:1112-1118
16. Craen M, Du Caju MVL, Bourguignon JP, Ernould C, Malvaux P, Vandeweghe M, Wolter R, Vanderschueren-Lodeweyckx M 1982 Effects of oral treatment with DHEAS in girls with hypopituitarism. Pediatr Res 16:888 (Abstract)
17. Marshall W, Tanner J 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
18. Ge X, Lorenz FO, Conger RD, Elder GH, Simons RL 1994 Trajectories of stressful life events and depressive symptoms during adolescence. Dev Psychol 30:467-483
19. Essau CA, Groen G, Conradt J, TurbanischU, PetermannF 2001 Validitatund Reliabilität der SCL-90-R: Ergebnisse der Bremer Jugendstudie. ZDDP 22: 139 -152
20. Radloff LS 1977 The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1:385-401
21. Steinhausen HC, Metzke CW 2000 [The General Depression Scale in diagnosis of adolescents]. Prax Kinderpsychol Kinderpsychiatr 49:419-434 (German)
22. Emlinger MW, Kühnel W, Ranke MB 2002 Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults. Clin Chem Lab Med 40:1151-1160
23. Ankarberg C, Norjavaara E 1999 Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls: correlation with 17β-estradiol and dehydroepiandrosterone sulfate. J Clin Endocrinol Metab 84:975-984
24. Rittner HL, Lee PD, Blum WF, Doerr HG, Steiss J, Kreuder J, Rascher W, Kiess W 1997 Developmental patterns of serum 3 α-androstanediol glucuronide. J Endocrinol Invest 20:245-250
25. Remer T, Boye KR, Hartmann MF, Wudy SA 2005 Urinary markers of adre- narche: reference values in healthy subjects, aged 3-18 years. J Clin Endocrinol Metab 90:2015-2221
26. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
27. Kleinbaum DG, Kupper LL, Morgenstern H 1982 Epidemiologic research: principles and quantitative methods. Belmont, CA: Lifetime Learning Publications. Sections 17.4, 17.5
28. Rittmaster RS 1993 Androgen conjugates: physiology and clinical significance. Endocr Rev 14:121-132
29. Labrie F, Bélanger A, Cusan L, Candas B 1997 Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active and rogens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 82:2403-2409